Results 61 to 70 of about 5,245,251 (341)

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?

Российский кардиологический журнал, 2014
The review provides the current information about the role of antiplatelet therapy in the cardiovascular prevention in patients with coronary artery disease and coronary revascularization.
Yu. I. Grinschtein, A. A. Kosinova, I. Yu. Grinschtein   +2 more
doaj   +1 more source

Long-Term Safety and Efficacy of Antiplatelet Therapy in Patients With Cerebral Infarction With Thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis, 2021
This study aimed to investigate the long-term safety and benefits of antiplatelet therapy in patients with cerebral infarction with thrombocytopenia, as evidence regarding this was limited.
Shijie Guo MD, Yingying Lin MD, Xiaoye Ma MD, Yanxin Zhao MD, Aiping Jin MD, Xueyuan Liu MD, Letao Sun MD, Guilin Meng MD   +7 more
doaj   +1 more source

The effects and safety of anticoagulation or antiplatelet therapy following TIPS in cirrhotic patients with portal hypertension: A meta-analysis

Frontiers in Pharmacology, 2023
Introduction: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective way to improve portal hypertension, however, the role of anticoagulation or antiplatelet therapy following TIPS remains controversial.
Xiaotong Xu, Yunlai Fu, Minjie Jiang, Muchen Wu, Jing Wu, Qinghua Meng   +5 more
doaj   +1 more source

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2019
Importance Data on P2Y12 inhibitor monotherapy after short-duration dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention are limited.
J. Hahn, Y. Song, J. Oh, W. Chun, Yong Hwan Park, W. Jang, E. Im, J. Jeong, B. Cho, S. Oh, K. Yun, D. Cho, Jong-Young Lee, Young‐Youp Koh, J. Bae, Jaewoong Choi, Wang-Soo Lee, H. Yoon, S. U. Lee, Jang-hyun Cho, W. Choi, S. Rha, J. Lee, T. Park, Jeong Hoon Yang, Jin‐Ho Choi, S. Choi, Sang Hoon Lee, H. Gwon   +28 more
semanticscholar   +1 more source

Assessing a 600-mg Loading Dose of Clopidogrel 24 Hours Prior to Pipeline Embolization Device Treatment [PDF]

, 2018
Background: Clopidogrel/aspirin antiplatelet therapy routinely is administered 7-10 days before pipeline aneurysm treatment. Our study assessed the safety and efficacy of a 600-mg loading dose of clopidogrel 24 hours before Pipeline Embolization Device ...
Atallah, MD, Elias, Bekelis, MD, Kimon, Chalouhi, MD, Nohra, Hasan, MD, David, Jabbour, Pascal, MD, Rosenwasser, MD, MBA, FACS, FAHA, Robert H., Saad, MD, Hassan, Smith, MD, Michelle, Tjoumakaris, MD, Stavropoula, Zarzour, MD, Hekmat   +9 more
core   +2 more sources

Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang, Chengsong Yue, Zhuang Li, Xiaolei Shi, Haoxuan Zhu, Jie Yang, Linyu Li, Jiaxing Song, Shitao Fan, Gaoming Li, Wenzhe Sun, Zhixian Ye, Jiacheng Huang, Dahong Yang, Jinfu Ma, Xu Xu, Zhixi Wang, Lilan Wang, Guojian Liu, Fengli Li, Changwei Guo, Li Qi, Wenjie Zi   +22 more
wiley   +1 more source

Bleeding complications related to external ventricular drainage placement in patients with ruptured intracranial aneurysms: a single-center study

Frontiers in Surgery
ObjectiveAcute aneurysmal rupture can be treated with endovascular therapy or surgical clipping. For patients with concurrent acute hydrocephalus, the placement of an external ventricular drainage (EVD) is required.
Yue Tang, Xiangping Zhong, Tingting Lin, Fujun Zuo, Min Fu, Li Wang, Xiaodu Yu, Dong Liu, Jincan Zhang   +8 more
doaj   +1 more source

Renal artery stenosis-when to screen, what to stent? [PDF]

, 2014
Renal artery stensosis (RAS) continues to be a problem for clinicians, with no clear consensus on how to investigate and assess the clinical significance of stenotic lesions and manage the findings.
A Losito, A Persu, AH Cragg, Alison Severn, Antiplatelet Trialists’ Collaboration, AR Chade, AT Hirsch, B Bruyne De, B Drieghe, B Girolami, BC Jaarsveld van, BH Gray, C Chrysochou, C Chrysochou, C Rountas, CG Missouris, CJ Cooper, CJ Cooper, Claudine G. Jennings, CM Cheung, D Blondin, D Lao, D Mukherjee, DFJ Tollefson, DG Hackam, DP Slovut, DTNA Berg van den, E Balk, FH Messerli, GA McKenzie, GBC Vasbinder, GBC Vasbinder, GJ Williams, H Tan, H Weibull, Isla S. Mackenzie, J Ritchie, J Webster, JL Zhang, John G. Houston, JP Beregi, JV Smit, JW Olin, JW Olin, K Rocha-Singh, K Wheatley, KA Gillis, KJ Hansen, L Bax, L Trinquart, LD Dworkin, LE Ramsay, LM Messina, LU Mailloux, M Seddon, MC Bates, MJ Bloch, MT Caps, MW Burket, OW Kincaid, P Liang, PJ Conlon, PJG Ven van de, PJG Ven van de, Renal Association, S Anand, S Savard, S Willoteaux, Samira Bell, SC Textor, SC Textor, SC Textor, SJ Gandy, SJ Gandy, SM Begelman, SW Lim, T Jonason, Thomas M. MacDonald, TP Murphy, VS Silva, WJ Jean   +80 more
core   +4 more sources

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li, Guilin Meng, Zijie Wang, Xiao Hu, Jing Cheng, Chu Chen, Tiannan Yang, Jiaxin Luo, Zizhen Meng, Xueyun Liu, Qi Li   +10 more
wiley   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source